fluorouracil has been researched along with Angor Pectoris in 50 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angina pectoris, arrhythmic sudden death and myocardial infarction, all these cardiac events have occasionally been reported during 5-fluorouracil (5-FU) chemotherapy." | 7.72 | High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients. ( Lersch, C; Reindl, L; Scherpinski, U; Seyfarth, M; Wacker, A, 2003) |
| "An 85-year-old woman, with known stable angina pectoris, was prescribed 5-fluorouracil cream to treat a small basal cell carcinoma on the forehead." | 7.69 | Myocardial ischemia induced by topical use of 5-fluorouracil. ( Gotsman, MS; Gurewich, J; Rozenman, Y, 1995) |
| "Favorable results have been reported for the treatment of advanced colorectal cancer with the combination of 5-fluorouracil (5-FU) and leucovorin (LV)." | 7.67 | Lack of effectiveness of combined 5-fluorouracil and leucovorin in patients with 5-fluorouracil-resistant advanced colorectal cancer. ( Peters, GJ; Pinedo, HM; van Groeningen, CJ, 1989) |
| "Two cases of 5-Fluorouracil (5FU) cardiotoxicity, chest pain with changes in ECG the former, and myocardial infarction the latter, are described." | 4.77 | [Cardiotoxicity of 5-fluorouracil. Personal cases and review of the literature]. ( Beretta, GD; Borsotti, E; Calasso, F; Carini, L; De Ceglia, S; Labianca, R; Rocca, A; Segalini, G, 1987) |
| "Two cases of 5-fluorouracil cardiotoxicity, resulting in one patient in myocardial infarction, are described." | 4.76 | 5-Fuorouracil cardiotoxicity. ( Guindani, A; Pagnoni, A; Villani, F, 1979) |
| " We report the detailed assessment of few cardiac parameter of toxicity in patients of advanced colorectal carcinoma subjected to two Schedules of high and low dose Folinic Acid, 5-Fluorouracil, bolus and continuous infusion." | 3.79 | Comparative cardiac toxicity in two treatment schedules of 5-FU/LV for colorectal carcinoma. ( Bano, N; Mateen, A; Najam, R, 2013) |
| "Angina pectoris, arrhythmic sudden death and myocardial infarction, all these cardiac events have occasionally been reported during 5-fluorouracil (5-FU) chemotherapy." | 3.72 | High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients. ( Lersch, C; Reindl, L; Scherpinski, U; Seyfarth, M; Wacker, A, 2003) |
| "An 85-year-old woman, with known stable angina pectoris, was prescribed 5-fluorouracil cream to treat a small basal cell carcinoma on the forehead." | 3.69 | Myocardial ischemia induced by topical use of 5-fluorouracil. ( Gotsman, MS; Gurewich, J; Rozenman, Y, 1995) |
| "Favorable results have been reported for the treatment of advanced colorectal cancer with the combination of 5-fluorouracil (5-FU) and leucovorin (LV)." | 3.67 | Lack of effectiveness of combined 5-fluorouracil and leucovorin in patients with 5-fluorouracil-resistant advanced colorectal cancer. ( Peters, GJ; Pinedo, HM; van Groeningen, CJ, 1989) |
| "A 43-year-old man with a history of colon cancer developed typical angina during intravenous infusion of 5-FU." | 2.46 | Angina induced by 5-fluorouracil infusion in a patient with normal coronaries. ( Movahed, MR; Saadat, H; Taherkhani, M; Tajik, R, 2010) |
| "5-Fluorouracil (5FU) cardiotoxicity is thought to be an infrequent toxic effect, usually related to coronary vasospasm." | 2.38 | [Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases]. ( Bachaud, JM; Bugat, R; Chevreau, C; de Forni, M; Delay, M; Sorbette, F, 1990) |
| "The case of an 83-year-old man with colon cancer who developed chest pain during 5-FU infusion is presented." | 1.38 | A case of severe coronary spasm associated with 5-fluorouracil chemotherapy. ( Cho, WH; Choi, SK; Kim, SB; Kim, SM; Kwak, CH; Lee, B; Sir, JJ, 2012) |
| " The most (even if not fully) effective strategy was reducing capecitabine dosage together with nitrates, calcium-channel blockers and trimetazidine therapy." | 1.36 | Capecitabine cardiac toxicity presenting as effort angina: a case report. ( Crivellari, D; Lestuzzi, C; Meneguzzo, N; Rigo, F; Viel, E, 2010) |
| " Coronary spasm is the most commonly suspected hypothesis, but further studies are warranted to seek for toxic inflammatory lesions of the myocardium (apoptosis, necrosis, fibrosis)." | 1.33 | Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease. ( Barel, C; Belkhiria, M; Bui-Xuan, B; Descotes, J; Lombard-Bohas, C; Tabib, A; Timour, Q; Tsibiribi, P, 2006) |
| "Capecitabine is a new chemotherapeutic agent considered highly specific for sensitive tumour cells, which convert the drug to 5-fluorouracil." | 1.33 | Coronary artery spasm induced by capecitabine. ( Barone, C; Cassano, A; Crea, F; Lanza, GA; Pozzo, C; Sestito, A; Sgueglia, GA, 2006) |
| "Cardiotoxicity is a rare but serious side effect of 5-flourouracil (5-FU)." | 1.31 | Cardiotoxicity of 5-flourouracil: two case reports. ( Ayanoğlu, E; Caymaz, O; Duman, D; Inanli, S; Tutkun, A, 2001) |
| "Capecitabine is a member of a new class of oral fluoropyrimidines." | 1.31 | Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil. ( Andrasch, H; Beck, FJ; Frickhofen, N; Fuhr, HG; Jung, B; Sigmund, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (40.00) | 18.7374 |
| 1990's | 9 (18.00) | 18.2507 |
| 2000's | 17 (34.00) | 29.6817 |
| 2010's | 4 (8.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Najam, R | 1 |
| Bano, N | 1 |
| Mateen, A | 1 |
| Farina, A | 1 |
| Malafronte, C | 1 |
| Valsecchi, MA | 1 |
| Achilli, F | 1 |
| Lestuzzi, C | 1 |
| Crivellari, D | 1 |
| Rigo, F | 1 |
| Viel, E | 1 |
| Meneguzzo, N | 1 |
| Tajik, R | 1 |
| Saadat, H | 1 |
| Taherkhani, M | 1 |
| Movahed, MR | 1 |
| Kim, SM | 1 |
| Kwak, CH | 1 |
| Lee, B | 1 |
| Kim, SB | 1 |
| Sir, JJ | 1 |
| Cho, WH | 1 |
| Choi, SK | 1 |
| Görgülü, S | 1 |
| Oğuz, E | 1 |
| Zor, A | 1 |
| Zor, U | 1 |
| Gürdoğan, M | 1 |
| Tezel, T | 1 |
| Yokoyama, T | 1 |
| Hosoya, Y | 1 |
| Aoki, T | 1 |
| Saito, S | 1 |
| Nihei, Y | 1 |
| Kobayashi, N | 1 |
| Shoji, M | 1 |
| Saito, Y | 1 |
| Nagai, H | 1 |
| Cianci, G | 1 |
| Morelli, MF | 1 |
| Cannita, K | 1 |
| Morese, R | 1 |
| Ricevuto, E | 1 |
| Di Rocco, ZC | 1 |
| Porzio, G | 1 |
| Lanfiuti Baldi, P | 1 |
| Ficorella, C | 1 |
| Grześk, G | 1 |
| Orzałkiewicz, Z | 1 |
| Polak, G | 1 |
| Przybył, R | 1 |
| Nartowicz, E | 1 |
| Szadujkis-Szadurski, L | 1 |
| Grabczewska, Z | 1 |
| Wacker, A | 1 |
| Lersch, C | 1 |
| Scherpinski, U | 1 |
| Reindl, L | 1 |
| Seyfarth, M | 1 |
| Pop, C | 1 |
| Nica, R | 1 |
| Vlaicu, R | 1 |
| Vinereanu, D | 1 |
| Maciá-Escalante, S | 1 |
| Guillén-Ponce, C | 1 |
| Molina-Garrido, MJ | 1 |
| Carrato-Mena, A | 1 |
| Vivas, Y | 1 |
| Chrissoheris, M | 1 |
| Tsibiribi, P | 1 |
| Descotes, J | 1 |
| Lombard-Bohas, C | 1 |
| Barel, C | 1 |
| Bui-Xuan, B | 1 |
| Belkhiria, M | 1 |
| Tabib, A | 1 |
| Timour, Q | 1 |
| Sestito, A | 1 |
| Sgueglia, GA | 1 |
| Pozzo, C | 1 |
| Cassano, A | 1 |
| Barone, C | 1 |
| Crea, F | 1 |
| Lanza, GA | 1 |
| Gundling, F | 1 |
| Fuchs, M | 1 |
| Nowak, L | 1 |
| Antoni, D | 1 |
| Hoffmann, E | 1 |
| Schepp, W | 1 |
| Spencker, S | 1 |
| Schmittel, A | 1 |
| Westermann, D | 1 |
| Marek, A | 1 |
| Schultheiss, HP | 1 |
| Witzenbichler, B | 1 |
| Coughlin, S | 1 |
| Das, S | 1 |
| Lee, J | 1 |
| Cooper, J | 1 |
| Underwood, DA | 1 |
| Groppe, CW | 1 |
| Tsai, AR | 1 |
| Yiannikas, J | 1 |
| Heupler, FA | 1 |
| Beretta, G | 2 |
| Labianca, R | 4 |
| Montinari, F | 1 |
| Luporini, G | 3 |
| Clerici, M | 1 |
| Fraschini, P | 1 |
| Dworken, HJ | 1 |
| Botti, RE | 1 |
| Gamucci, T | 1 |
| Zampa, G | 1 |
| Rozenman, Y | 1 |
| Gurewich, J | 1 |
| Gotsman, MS | 1 |
| Rexroth, G | 1 |
| Scotland, V | 1 |
| Weidmann, B | 1 |
| Teipel, A | 1 |
| Niederle, N | 1 |
| Anderson, NR | 1 |
| Lokich, JJ | 1 |
| Moore, C | 1 |
| Cassidy, J | 1 |
| Tutkun, A | 1 |
| Inanli, S | 1 |
| Caymaz, O | 1 |
| Ayanoğlu, E | 1 |
| Duman, D | 1 |
| Maseri, A | 1 |
| Lanza, G | 1 |
| Frickhofen, N | 1 |
| Beck, FJ | 1 |
| Jung, B | 1 |
| Fuhr, HG | 1 |
| Andrasch, H | 1 |
| Sigmund, M | 1 |
| Dent, RG | 1 |
| McColl, I | 1 |
| Stevenson, DL | 1 |
| Mikhailidis, DP | 1 |
| Gillett, DS | 1 |
| Villani, F | 1 |
| Guindani, A | 1 |
| Pagnoni, A | 1 |
| Zeymer, U | 1 |
| Neuhaus, KL | 1 |
| Lomeo, AM | 1 |
| Avolio, C | 1 |
| Iacobellis, G | 1 |
| Manzione, L | 1 |
| de Forni, M | 1 |
| Bugat, R | 1 |
| Sorbette, F | 1 |
| Delay, M | 1 |
| Bachaud, JM | 1 |
| Chevreau, C | 1 |
| Spain, M | 1 |
| McPherson, D | 1 |
| van Groeningen, CJ | 1 |
| Peters, GJ | 1 |
| Pinedo, HM | 1 |
| Fosså, SD | 1 |
| Dahl, O | 1 |
| Hoel, R | 1 |
| Heier, M | 1 |
| Loeb, M | 1 |
| Sponzilli, C | 1 |
| Toff, W | 1 |
| Oleksowicz, L | 1 |
| Bruckner, HW | 1 |
| Bastion, Y | 1 |
| Piperno, D | 1 |
| Pacheco, Y | 1 |
| Gormand, F | 1 |
| Rebatu, P | 1 |
| Perrin-Fayolle, M | 1 |
| Segalini, G | 1 |
| Beretta, GD | 1 |
| Borsotti, E | 1 |
| Calasso, F | 1 |
| Carini, L | 1 |
| De Ceglia, S | 1 |
| Rocca, A | 1 |
| Eskilsson, J | 1 |
| Albertsson, M | 1 |
| Manegold, C | 1 |
| Thomas, H | 1 |
| Richter, C | 1 |
| Rettenmaier, G | 1 |
| Baker, WP | 1 |
| Dainer, P | 1 |
| Lester, WM | 1 |
| Marty, AM | 1 |
| Blair, TP | 1 |
| Blijham, GH | 1 |
| Fiolet, HH | 1 |
| van Deijk, WA | 1 |
| Hupperets, PS | 1 |
| Janssen, JH | 1 |
| Mancuso, L | 1 |
| Bondì, F | 1 |
| Marchì, S | 1 |
| Iacona, MA | 1 |
| Di Gregorio, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase Ⅱ Clinical Study of RALOX or CAPOX Combined With Bevacizumab in the First-line Treatment of Advanced Colorectal Cancer[NCT03813641] | Phase 2 | 100 participants (Anticipated) | Interventional | 2019-01-28 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for fluorouracil and Angor Pectoris
| Article | Year |
|---|---|
Angina induced by 5-fluorouracil infusion in a patient with normal coronaries.
Topics: Adult; Angina Pectoris; Antimetabolites, Antineoplastic; Colonic Neoplasms; Coronary Angiography; Co | 2010 |
[Angina attack caused by 5-fluorouracil infusion--report of a case and review of the literature].
Topics: Angina Pectoris; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Isosorbide Dinitrate; Live | 2002 |
5-Fuorouracil cardiotoxicity.
Topics: Adult; Aged; Angina Pectoris; Electrocardiography; Female; Fluorouracil; Heart; Humans; Male; Middle | 1979 |
[Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].
Topics: Adult; Aged; Angina Pectoris; Dose-Response Relationship, Drug; Electrocardiography; Female; Fluorou | 1990 |
[Cardiotoxicity of 5-fluorouracil. Personal cases and review of the literature].
Topics: Aged; Angina Pectoris; Female; Fluorouracil; Heart; Humans; Male; Myocardial Infarction | 1987 |
45 other studies available for fluorouracil and Angor Pectoris
| Article | Year |
|---|---|
Comparative cardiac toxicity in two treatment schedules of 5-FU/LV for colorectal carcinoma.
Topics: Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blood Pressure; Carcino | 2013 |
Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.
Topics: Angina Pectoris; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neop | 2009 |
Capecitabine cardiac toxicity presenting as effort angina: a case report.
Topics: Angina Pectoris; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Cardiovascular Age | 2010 |
A case of severe coronary spasm associated with 5-fluorouracil chemotherapy.
Topics: Aged, 80 and over; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Calcium Channel | 2012 |
A case of myocardial ischaemia induced by 5-fluorouracil.
Topics: Adenocarcinoma; Angina Pectoris; Antimetabolites, Antineoplastic; Colonic Neoplasms; Electrocardiogr | 2002 |
Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.
Topics: Aged; Angina Pectoris; Antimetabolites, Antineoplastic; Female; Fluorouracil; Humans; Male; Middle A | 2003 |
[Coronary artery stenting in the treatment of 5-fluorouracil-induced unstable angina].
Topics: Angina Pectoris; Antimetabolites, Antineoplastic; Colonic Neoplasms; Coronary Angiography; Dose-Resp | 2003 |
High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients.
Topics: Adult; Aged; Angina Pectoris; Antimetabolites, Antineoplastic; Coronary Angiography; Echocardiograph | 2003 |
Vasospastic angina caused by 5-fluorouracil. A case report.
Topics: Adenocarcinoma; Aged; Angina Pectoris; Antimetabolites, Antineoplastic; Colonic Neoplasms; Coronary | 2003 |
Patient with angina secondary to capecitabine.
Topics: Adenocarcinoma; Angina Pectoris; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothera | 2005 |
Electrocardiographic manifestations of 5-fluorouracil cardiotoxicity.
Topics: Aged; Angina Pectoris; Antimetabolites, Antineoplastic; Electrocardiography; Fluorouracil; Heart Con | 2005 |
Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.
Topics: Adult; Aged; Angina Pectoris; Antimetabolites, Antineoplastic; Cardiac Output, Low; Chest Pain; Fema | 2006 |
Coronary artery spasm induced by capecitabine.
Topics: Adult; Angina Pectoris; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Carcinoma, | 2006 |
["Iatrogenic acute coronary syndrome"--59 year old patient with adenocarcinoma of ascending colon and stenocardia while receiving adjuvant chemotherapy with 5-fluorouracil].
Topics: Adenocarcinoma; Angina Pectoris; Chemotherapy, Adjuvant; Colon, Ascending; Colonic Neoplasms; Fluoro | 2006 |
[Angina pectoris and ST-elevation after chemotherapy with 5-fluorouracil].
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Carc | 2007 |
Capecitabine induced vasospastic angina.
Topics: Angina Pectoris; Antimetabolites, Antineoplastic; Capecitabine; Coronary Vasospasm; Deoxycytidine; F | 2008 |
Coronary insufficiency and 5-fluorouracil therapy. A case report, review, and suggestion regarding mechanism.
Topics: Adenocarcinoma; Angina Pectoris; Fluorouracil; Humans; Male; Middle Aged; Sigmoid Neoplasms | 1983 |
Antitumor chemotherapy after fluorouracil angina.
Topics: Angina Pectoris; Breast Neoplasms; Creatine Kinase; Electrocardiography; Fluorouracil; Gastrointesti | 1982 |
Cardiac toxicity of 5-fluorouracil: a study on 1083 patients.
Topics: Aged; Angina Pectoris; Drug Therapy, Combination; Female; Fluorouracil; Heart; Humans; Male; Middle | 1982 |
Angina and anemia with marked valvular stenosis.
Topics: Adenocarcinoma; Aged; Anemia, Hypochromic; Angina Pectoris; Aortic Valve Stenosis; Colon; Colonic Ne | 1982 |
Cardiotoxicity of 5-fluorouracil.
Topics: Angina Pectoris; Colonic Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lomusti | 1980 |
Myocardial ischemia induced by topical use of 5-fluorouracil.
Topics: Administration, Topical; Aged; Aged, 80 and over; Angina Pectoris; Carcinoma, Basal Cell; Drug Thera | 1995 |
[Cardiac toxicity of 5-fluorouracil].
Topics: Adenocarcinoma; Angina Pectoris; Cardiomyopathies; Cecal Neoplasms; Colonic Neoplasms; Death, Sudden | 1994 |
The syndrome of 5-fluorouracil cardiotoxicity: an elusive cardiopathy.
Topics: Adenocarcinoma; Angina Pectoris; Electrocardiography; Female; Fluorouracil; Heart; Heart Diseases; H | 1994 |
The syndrome of 5-fluorouracil cardiotoxicity: an elusive cardiopathy.
Topics: Angina Pectoris; Fluorouracil; Heart Diseases; Humans; Myocardial Infarction | 1993 |
Iatrogenic chest pain--5-fluorouracil cardiotoxicity.
Topics: Angina Pectoris; Antimetabolites, Antineoplastic; Fluoroacetates; Fluorouracil; Humans | 1997 |
Cardiotoxicity of 5-flourouracil: two case reports.
Topics: Angina Pectoris; Atrial Fibrillation; Female; Fluorouracil; Heart; Humans; Male; Middle Aged; Myocar | 2001 |
Fluorouracil-induced coronary artery spasm.
Topics: Angina Pectoris; Antimetabolites, Antineoplastic; Coronary Vasospasm; Exercise Test; Fluorouracil; H | 2001 |
Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil.
Topics: Administration, Oral; Angina Pectoris; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Dose-Res | 2002 |
Letter: 5-Fluorouracil and angina.
Topics: Adult; Aged; Angina Pectoris; Female; Fluorouracil; Humans; Infusions, Parenteral; Injections, Intra | 1975 |
Cardiotoxicity of 5-fluorouracil.
Topics: Adenocarcinoma; Adult; Angina Pectoris; Cecal Neoplasms; Female; Fluorouracil; Humans | 1977 |
5-fluorouracil cardiotoxicity: the risk of rechallenge.
Topics: Angina Pectoris; Coronary Vasospasm; Fluorouracil; Humans; Myocardial Infarction; Recurrence | 1991 |
[The cardiotoxic side effects of 5-fluorouracil].
Topics: Angina Pectoris; Electrocardiography; Fluorouracil; Heart; Humans; Male; Middle Aged; Myocardial Inf | 1991 |
5-Fluorouracil cardiotoxicity.
Topics: Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intrad | 1990 |
5-Fluorouracil-induced angina.
Topics: Aged; Angina Pectoris; Coronary Vasospasm; Female; Fluorouracil; Humans; Liver Neoplasms; Platelet A | 1989 |
Lack of effectiveness of combined 5-fluorouracil and leucovorin in patients with 5-fluorouracil-resistant advanced colorectal cancer.
Topics: Adult; Aged; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; | 1989 |
Doxifluridine (5'-dFUrd) in patients with advanced colorectal carcinoma. A phase II study.
Topics: Angina Pectoris; Brain Diseases; Carcinoembryonic Antigen; Colonic Neoplasms; Drug Evaluation; Elect | 1985 |
Fluorouracil and angina.
Topics: Angina Pectoris; Female; Fluorouracil; Humans; Middle Aged | 1987 |
Prophylaxis of 5-fluorouracil-induced coronary vasospasm with calcium channel blockers.
Topics: Aged; Angina Pectoris; Coronary Vasospasm; Female; Fluorouracil; Humans; Nifedipine | 1988 |
[Anginal pain from 5-fluorouracil].
Topics: Angina Pectoris; Fluorouracil; Humans; Male; Middle Aged | 1988 |
[Severe adverse cardiac effects during treatment with cisplatin and 5-fluorouracil].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cisplatin; Fluorouracil; Humans | 1988 |
[Angina pectoris during regional chemotherapy of liver metastases].
Topics: Angina Pectoris; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms | 1987 |
Ischemic chest pain after 5-fluorouracil therapy for cancer.
Topics: Angina Pectoris; Coronary Vessels; Fluorouracil; Hemodynamics; Humans; Male; Middle Aged; Myocardium | 1986 |
Angina pectoris associated with infusions of 5-FU and vindesine.
Topics: Aged; Angina Pectoris; Female; Fluorouracil; Humans; Middle Aged; Vindesine | 1986 |
Cardiac toxicity of 5-fluorouracil. Report of a case of spontaneous angina.
Topics: Angina Pectoris; Colonic Neoplasms; Electrocardiography; Fluorouracil; Humans; Liver Neoplasms; Male | 1986 |